Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. It offers Trisus, a cloud-native healthcare financial intelligence platform that unifies data, revenue and margin insights, and operational analytics;…more
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. It offers Trisus, a cloud-native healthcare financial intelligence platform that unifies data, revenue and margin insights, and operational analytics;…more
Latest RNS from Craneware plc
- holdingsNotification of Major Holdings
- agm_noticePosting of Annual Report and Notice of AGM
- tvrTotal Voting Rights
- final_resultsFY26 Final Results
- trading_updateFY26 Trading Update
Analyst consensus: Buy
As of 10 Nov 2026, 4 analysts rate Craneware plc a Buy, with 100% buy ratings and a mean price target of 1,784p (range 1,594p–1,972p), +77% vs the current price.